Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
Timothy Perera(Deutz (Germany)), Matthew V. Lorenzi(Johnson & Johnson (United States))
Cited by 338
Related Papers
Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers
|Journal of Translational Medicine|2013|75